|
Name |
Gentisyl alcohol
|
Molecular Formula | C7H8O3 | |
IUPAC Name* |
2-(hydroxymethyl)benzene-1,4-diol
|
|
SMILES |
C1=CC(=C(C=C1O)CO)O
|
|
InChI |
InChI=1S/C7H8O3/c8-4-5-3-6(9)1-2-7(5)10/h1-3,8-10H,4H2
|
|
InChIKey |
PUZSUVGRVHEUQO-UHFFFAOYSA-N
|
|
Synonyms |
Gentisyl alcohol; 2-(hydroxymethyl)benzene-1,4-diol; 495-08-9; 2,5-Dihydroxybenzyl alcohol; Salirepol; 3,6-Dihydroxybenzyl alcohol; 2-(hydroxymethyl)-1,4-benzenediol; gentisin alcohol; 1,4-Benzenediol, 2-(hydroxymethyl)-; T8T2WY38GH; CHEBI:5325; UNII-T8T2WY38GH; GENTISYL ALCOHOL [MI]; SCHEMBL829492; CHEMBL448800; PUZSUVGRVHEUQO-UHFFFAOYSA-; DTXSID60197804; ZINC900388; BE-53594B; MFCD06202616; 2-(hydroxymethyl)-benzene-1,4-diol; AKOS006293496; BS-1180; CS-0378114; E88042; EN300-1843206; A819991; Q27106721; 2,5-DIHYDROXYBENZYL ALCOHOL, HYDROXYMETHYL-HYDROCHINONE; 2-(hydroxymethyl)benzene-1,4-diol;3,5-Dihydroxybenzyl Alcohol; 2,5-Dihydroxybenzyl alcohol; Gentisyl alcohol; Salirepol; Gentisin alcohol
|
|
CAS | 495-08-9 | |
PubChem CID | 188287 | |
ChEMBL ID | CHEMBL448800 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 140.14 | ALogp: | 0.7 |
HBD: | 3 | HBA: | 3 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 60.7 | Aromatic Rings: | 1 |
Heavy Atoms: | 10 | QED Weighted: | 0.51 |
Caco-2 Permeability: | -4.559 | MDCK Permeability: | 0.00000914 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.032 | 20% Bioavailability (F20%): | 0.939 |
30% Bioavailability (F30%): | 0.922 |
Blood-Brain-Barrier Penetration (BBB): | 0.032 | Plasma Protein Binding (PPB): | 29.29% |
Volume Distribution (VD): | 0.966 | Fu: | 67.86% |
CYP1A2-inhibitor: | 0.24 | CYP1A2-substrate: | 0.23 |
CYP2C19-inhibitor: | 0.05 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.017 | CYP2C9-substrate: | 0.715 |
CYP2D6-inhibitor: | 0.075 | CYP2D6-substrate: | 0.791 |
CYP3A4-inhibitor: | 0.035 | CYP3A4-substrate: | 0.15 |
Clearance (CL): | 14.215 | Half-life (T1/2): | 0.944 |
hERG Blockers: | 0.022 | Human Hepatotoxicity (H-HT): | 0.031 |
Drug-inuced Liver Injury (DILI): | 0.045 | AMES Toxicity: | 0.625 |
Rat Oral Acute Toxicity: | 0.527 | Maximum Recommended Daily Dose: | 0.018 |
Skin Sensitization: | 0.917 | Carcinogencity: | 0.359 |
Eye Corrosion: | 0.255 | Eye Irritation: | 0.979 |
Respiratory Toxicity: | 0.113 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002875 | 0.514 | D02ZJI | 0.440 | ||||
ENC000097 | 0.514 | D0K5CB | 0.440 | ||||
ENC000696 | 0.500 | D07MOX | 0.405 | ||||
ENC000069 | 0.474 | D0YF3X | 0.392 | ||||
ENC000344 | 0.474 | D0T7OW | 0.390 | ||||
ENC002464 | 0.455 | D04PHC | 0.378 | ||||
ENC000500 | 0.450 | D08HVR | 0.362 | ||||
ENC000003 | 0.444 | D03UOT | 0.361 | ||||
ENC000734 | 0.421 | D0V9EN | 0.348 | ||||
ENC002506 | 0.421 | D0BA6T | 0.347 |